Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Proactive Drug Monitoring Is Associated With Higher Persistence to Infliximab and Adalimumab Treatment and Lower Healthcare Utilization Compared With Reactive and Clinical Monitoring”.
Mazen Tolaymat, Sara Brown, Barathi Sivasailam, Raymond K. Cross, Nauroz Syed
Barathi Sivasailam, Madeline Alizadeh, Lisa Malter, Jordan E. Axelrad, Sharon Klein